Menlo Park, CA, United States of America

Oliver Claude Venn

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Menlo Park, CA (US) (2022 - 2024)
  • San Francisco, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Oliver Claude Venn: Innovator in Cancer Detection

Introduction

Oliver Claude Venn is a prominent inventor based in Menlo Park, California. He has made significant contributions to the field of cancer diagnostics, holding a total of 11 patents. His work focuses on innovative methods for detecting cancer-specific methylation patterns, which are crucial for early diagnosis and treatment.

Latest Patents

Among his latest patents is a cancer assay panel designed for targeted detection of cancer-specific methylation patterns. This patent outlines methods for designing, making, and using the cancer assay panel for the diagnosis of cancer. The development of such a panel represents a significant advancement in the field of oncology, providing healthcare professionals with essential tools for early detection.

Career Highlights

Oliver currently works at Grail, Inc., a company dedicated to transforming cancer detection through innovative technology. His role at Grail has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research that aims to improve patient outcomes.

Collaborations

Some of his notable coworkers include Samuel S. Gross and Arash Jamshidi. Their combined expertise fosters a collaborative environment that drives innovation and enhances the development of new diagnostic tools.

Conclusion

Oliver Claude Venn's work in cancer detection exemplifies the impact of innovation in healthcare. His contributions through patents and collaboration with other experts continue to pave the way for advancements in cancer diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…